 | • レポートコード：MRC2304F179 • 出版社/出版日：360iResearch / 2022年10月 • レポート形態：英語、PDF、258ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医薬品 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の本調査レポートによると、2021年に179.32百万ドルであった世界の色素内視鏡検査用薬剤市場規模は2022年に191.02百万ドルになり、更に年平均6.70％拡大して2027年までに264.63百万ドルに達する見通しです。本書は、色素内視鏡検査用薬剤の世界市場についての多面的な調査を元に、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、製品別（吸収剤、造影剤、反応剤）分析、用途別（結腸直腸、食道、胃）分析、エンドユーザー別（外来手術センター、診断センター、病院、専門クリニック）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報などの内容をまとめた市場調査レポートです。なお、本書に掲載されている企業情報には、Bayer AG、Bracco Diagnostics, Inc.、Cosmo Pharmaceuticals、Daiichi Sankyo Co. Ltd.、Dobro Produkt & Service、Enzo Life Sciences, Inc.、Fluitek Corporation、Fuji Pharma Co. Ltd、GE Healthcare、Guerbet LLC、Hapuflam Gmbhなどが含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界の色素内視鏡検査用薬剤市場規模：製品別 - 吸収剤の市場規模 - 造影剤の市場規模 - 反応剤の市場規模 ・世界の色素内視鏡検査用薬剤市場規模：用途別 - 結腸直腸における市場規模 - 食道における市場規模 - 胃における市場規模 ・世界の色素内視鏡検査用薬剤市場規模：エンドユーザー別 - 外来手術センターにおける市場規模 - 診断センターにおける市場規模 - 病院における市場規模 - 専門クリニックにおける市場規模 ・世界の色素内視鏡検査用薬剤市場規模：地域別 - 南北アメリカの色素内視鏡検査用薬剤市場規模 アメリカの色素内視鏡検査用薬剤市場規模 カナダの色素内視鏡検査用薬剤市場規模 ブラジルの色素内視鏡検査用薬剤市場規模 ... - アジア太平洋の色素内視鏡検査用薬剤市場規模 日本の色素内視鏡検査用薬剤市場規模 中国の色素内視鏡検査用薬剤市場規模 インドの色素内視鏡検査用薬剤市場規模 韓国の色素内視鏡検査用薬剤市場規模 台湾の色素内視鏡検査用薬剤市場規模 ... - ヨーロッパ/中東/アフリカの色素内視鏡検査用薬剤市場規模 イギリスの色素内視鏡検査用薬剤市場規模 ドイツの色素内視鏡検査用薬剤市場規模 フランスの色素内視鏡検査用薬剤市場規模 ロシアの色素内視鏡検査用薬剤市場規模 ... - その他地域の色素内視鏡検査用薬剤市場規模 ・競争状況 ・企業情報 |
The Global Chromoendoscopy Agents Market size was estimated at USD 179.32 million in 2021 and expected to reach USD 191.02 million in 2022, and is projected to grow at a CAGR 6.70% to reach USD 264.63 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Chromoendoscopy Agents to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Absorptive Agents, Contrast Agents, and Reactive Agents.
Based on Application, the market was studied across Colorectal, Esophageal, and Gastric.
Based on End User, the market was studied across Ambulatory Surgery Centers, Diagnostic Centers, Hospitals, and Specialty Clinics.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Chromoendoscopy Agents market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Chromoendoscopy Agents Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Chromoendoscopy Agents Market, including Bayer AG, Bracco Diagnostics, Inc., Cosmo Pharmaceuticals, Daiichi Sankyo Co. Ltd., Dobro Produkt & Service, Enzo Life Sciences, Inc., Fluitek Corporation, Fuji Pharma Co. Ltd, GE Healthcare, Guerbet LLC, Hapuflam Gmbh, Helios Lubeoil Gmbh Co. Kg, Histalim, Isola Vermiculite Gmbh, Lantheus Medical Imaging, Inc., LobaChemie Pvt. Ltd., Merck & Co., Inc., Pronol Gmbh Ölunfall-vorsorge, Provepharm life Solutions SA, Rench Chemie Gmbh, Schröder KG, Sisco Research Laboratories Pvt. Ltd., and Thermo Fisher Scientific.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Chromoendoscopy Agents Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Chromoendoscopy Agents Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Chromoendoscopy Agents Market?
4. What is the competitive strategic window for opportunities in the Global Chromoendoscopy Agents Market?
5. What are the technology trends and regulatory frameworks in the Global Chromoendoscopy Agents Market?
6. What is the market share of the leading vendors in the Global Chromoendoscopy Agents Market?
7. What modes and strategic moves are considered suitable for entering the Global Chromoendoscopy Agents Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing the prevalence of gastrointestinal diseases
5.1.1.2. Increase in the number of endoscopy procedures
5.1.1.3. Surge in awareness among people about preventive measures of cancer
5.1.2. Restraints
5.1.2.1. Unavailability of trained professionals
5.1.3. Opportunities
5.1.3.1. Increased spending of the government for strengthening the healthcare sector
5.1.3.2. Adoption of various advanced medical techniques
5.1.4. Challenges
5.1.4.1. Extensive use of alternative technique
5.2. Cumulative Impact of COVID-19
6. Chromoendoscopy Agents Market, by Product
6.1. Introduction
6.2. Absorptive Agents
6.3. Contrast Agents
6.4. Reactive Agents
7. Chromoendoscopy Agents Market, by Application
7.1. Introduction
7.2. Colorectal
7.3. Esophageal
7.4. Gastric
8. Chromoendoscopy Agents Market, by End User
8.1. Introduction
8.2. Ambulatory Surgery Centers
8.3. Diagnostic Centers
8.4. Hospitals
8.5. Specialty Clinics
9. Americas Chromoendoscopy Agents Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Chromoendoscopy Agents Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Chromoendoscopy Agents Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Bayer AG
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Bracco Diagnostics, Inc.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Cosmo Pharmaceuticals
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Daiichi Sankyo Co. Ltd.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Dobro Produkt & Service
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Enzo Life Sciences, Inc.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Fluitek Corporation
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Fuji Pharma Co. Ltd
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. GE Healthcare
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Guerbet LLC
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Hapuflam Gmbh
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Helios Lubeoil Gmbh Co. Kg
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Histalim
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Isola Vermiculite Gmbh
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Lantheus Medical Imaging, Inc.
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. LobaChemie Pvt. Ltd.
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Merck & Co., Inc.
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Pronol Gmbh Ölunfall-vorsorge
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Provepharm life Solutions SA
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Rench Chemie Gmbh
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Schröder KG
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Sisco Research Laboratories Pvt. Ltd.
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services
13.23. Thermo Fisher Scientific
13.23.1. Business Overview
13.23.2. Key Executives
13.23.3. Product & Services
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing